Neuroone Medical Technologies (NMTC) Invested Capital (2016 - 2025)
Neuroone Medical Technologies (NMTC) has disclosed Invested Capital for 14 consecutive years, with $6.4 million as the latest value for Q4 2025.
- For the quarter ending Q4 2025, Invested Capital rose 118.1% year-over-year to $6.4 million, compared with a TTM value of $6.4 million through Dec 2025, up 118.1%, and an annual FY2025 reading of $7.1 million, up 760.39% over the prior year.
- Invested Capital was $6.4 million for Q4 2025 at Neuroone Medical Technologies, down from $7.1 million in the prior quarter.
- Across five years, Invested Capital topped out at $15.9 million in Q4 2021 and bottomed at $822013.0 in Q3 2024.
- Average Invested Capital over 5 years is $6.9 million, with a median of $6.5 million recorded in 2021.
- The sharpest move saw Invested Capital soared 1032.53% in 2021, then tumbled 87.11% in 2024.
- Year by year, Invested Capital stood at $15.9 million in 2021, then crashed by 48.76% to $8.2 million in 2022, then crashed by 45.93% to $4.4 million in 2023, then crashed by 33.56% to $2.9 million in 2024, then skyrocketed by 118.1% to $6.4 million in 2025.
- Business Quant data shows Invested Capital for NMTC at $6.4 million in Q4 2025, $7.1 million in Q3 2025, and $8.2 million in Q2 2025.